2019

1. Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry

   Rheumatology International, Vol. 39, Núm. 3, pp. 509-515

2. Objectives and methodology of BIOBADASER phase III

   Reumatologia Clinica, Vol. 15, Núm. 4, pp. 229-236